September 27, 2024

Real-World Data Offering from Proscia: Empowering Life Sciences to Advance Precision Medicine Pipelines

From the Proscia blog: Following a successful year-long pilot with a subset of our biopharma and biotech partners, today we announced that life sciences organizations can now leverage Proscia’s real-world data offering on the Concentriq® platform to...

recent articles

Pathomation Invites You To Their Upcoming Customer Event in Dublin Dear customer/dear partner, We are excited to announce our upcoming customer event in Dublin! Join us on September 11th at 5pm for the launch of the new Pathomation Image...

Join Ibex at ECP 2023 in Dublin to learn how they transform cancer diagnosis by harnessing artificial intelligence to support routine practice at pathology labs worldwide. There will be three clinical presentations from studies conducted at...

HER2 IHC testing in the wake of the 2023 HER2 Breast Guideline Update Clinical Value, Classification & Scoring and the impact of the ASCO-CAP 2023 HER2 Breast Testing Guideline Update Over the past several months, the HER2/neu IHC...

DoMore Diagnostics and Proscia: Collaboration holds the promise to reduce overtreatment with integrated AI-powered pathology workflows OSLO and PHILADELPHIA – August 30, 2023 – DoMore Diagnostics, a leader in deep learning precision...

Lunit, a firm specializing in cancer diagnostics and therapeutics powered by artificial intelligence (AI), announced the presentation of data from a collaborative study on the use of the Lunit SCOPE IO test to predict immunotherapy treatment...

Initial analyses also show AI screening lowers associated radiologist image reading workload by half Both radiologists and pathologists analyze images to make cancer diagnoses, although one works with radiological images and the other works...

OR

platinum partners

gold partners

Silver Partners

Media Partners